CASI Pharmaceuticals reported asset growth of -32.49% for the quarter ended Jun 2026. These growth metrics cover 16 quarters of results from Jun 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth Ratios | ||||||||||||||||
| Assets Growth (1y) | -30.42% | -34.37% | -34.16% | -29.63% | -39.14% | -52.21% | -32.49% | |||||||||
| Assets Growth (3y) | -27.06% | -35.64% | -35.33% | |||||||||||||
| Assets (QoQ) | -8.14% | -11.90% | -4.68% | -11.62% | -23.95% | -23.56% | -21.60% | 4.86% | ||||||||
| Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) | -32.17% | 21.72% | -26.47% | -43.64% | -100.00% | -10.69% | -29.30% | -58.18% | -44.14% | |||||||
| Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) | -99.38% | -99.47% | -39.40% | |||||||||||||
| Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) | -100.00% | 1.94% | 18.10% | 235,842,911.61% | -100.00% | -21.87% | -19.09% | -38.15% | -30.49% | 20.21% | ||||||
| EBIT Growth (1y) | -3.68% | -46.22% | 10.88% | 77.10% | -31.07% | 5.95% | -66.12% | -276.83% | -9.78% | -26.58% | -26.15% | -497.75% | ||||
| EBIT Growth (3y) | -14.26% | -20.29% | -23.15% | -72.78% | ||||||||||||
| EBIT Margin Growth (1y) | -964.00 | -0.00B | -167.00 | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | ||||
| EBIT Margin Growth (3y) | -0.00B | -0.00B | -0.00B | -0.00B | ||||||||||||
| EBIT Margin (QoQ) | 222.00 | 0.00B | -0.00B | 0.00B | -875.00 | 0.00B | 779.00 | -0.00B | 0.00B | 0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |
| EBIT (QoQ) | 8.14% | 10.55% | -161.80% | 51.81% | -29.56% | 45.48% | 32.74% | -175.87% | 7.03% | 3.70% | -52.58% | 19.63% | -7.19% | 4.03% | -622.98% | |
| EBT Growth (1y) | -3.68% | -46.22% | 10.88% | 77.10% | -29.25% | 7.39% | -63.32% | -273.04% | -10.50% | -28.03% | -28.19% | -503.80% | ||||
| EBT Growth (3y) | -13.98% | -20.13% | -23.11% | -72.77% | ||||||||||||
| EBT Margin Growth (1y) | -964.00 | -0.00B | -167.00 | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | ||||
| EBT Margin Growth (3y) | -0.00B | -0.00B | -0.00B | -0.00B | ||||||||||||
| EBT Margin (QoQ) | 222.00 | 0.00B | -0.00B | 0.00B | -875.00 | 0.00B | 779.00 | -0.00B | 0.00B | 0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |
| EBT (QoQ) | 8.14% | 10.55% | -161.80% | 51.81% | -29.56% | 45.48% | 32.74% | -172.05% | 7.18% | 3.85% | -53.64% | 19.41% | -7.55% | 3.73% | -623.63% | |
| EPS (Basic) Growth (1y) | 26.13% | -12.95% | 14.08% | 33.37% | -44.32% | 28.88% | -64.75% | -30.21% | 0.74% | -60.13% | -12.58% | -1.30% | ||||
| EPS (Basic) Growth (3y) | -1.90% | -8.75% | -16.81% | 4.21% | ||||||||||||
| EPS (Basic) (QoQ) | -2.45% | 34.20% | -660,760,320.83% | 100.00% | -56.65% | 49.94% | -512,389,580.34% | 100.00% | 22.81% | -15.96% | -404,958,266.73% | 100.00% | -24.53% | 18.47% | -364,377,194.04% | |
| EPS (Diluted) Growth (1y) | 26.13% | -12.95% | 14.08% | 33.37% | -44.32% | 28.88% | -64.75% | -30.21% | 0.74% | -60.13% | -12.58% | -1.30% | ||||
| EPS (Diluted) Growth (3y) | -1.90% | -8.75% | -16.81% | 4.21% | ||||||||||||
| EPS (Diluted) (QoQ) | -2.45% | 34.20% | -660,760,320.83% | 100.00% | -56.65% | 49.94% | -512,389,580.34% | 100.00% | 22.81% | -15.96% | -404,958,266.73% | 100.00% | -24.53% | 18.47% | -364,377,194.04% | |
| Gross Margin Growth (1y) | 100.00 | 82.00 | 31.00 | -0.00B | -655.00 | -746.00 | -682.00 | -0.00B | 502.00 | -265.00 | -0.00B | 0.00B | ||||
| Gross Margin Growth (3y) | -53.00 | -930.00 | -0.00B | -0.00B | ||||||||||||
| Gross Margin (QoQ) | 6.00 | -18.00 | 0.00B | -0.00B | -12.00 | -69.00 | 32.00 | -607.00 | -103.00 | -4.00 | -0.00B | 0.00B | -870.00 | -0.00B | 0.00B | |
| Gross Profit Growth (1y) | -6.32% | 16.15% | -13.01% | -63.06% | -63.65% | -64.57% | -22.06% | -20.47% | 100.39% | -0.44% | -82.55% | 14.41% | ||||
| Gross Profit Growth (3y) | -11.96% | -25.73% | -50.90% | -30.47% | ||||||||||||
| Gross Profit (QoQ) | -5.30% | 18.77% | 84.16% | -54.77% | 17.41% | -11.04% | -21.79% | -55.51% | 14.45% | 95.69% | -20.20% | 12.11% | -43.13% | -65.69% | 423.09% | |
| Net Income Growth (1y) | 30.90% | -10.99% | 43.10% | 72.12% | -67.44% | 40.55% | -82.08% | -201.98% | -18.79% | -83.86% | -29.27% | -469.51% | ||||
| Net Income Growth (3y) | -11.18% | -6.66% | -10.22% | -68.62% | ||||||||||||
| Net Income (QoQ) | -35.35% | 26.14% | -113.91% | 67.69% | -117.42% | 62.14% | -4.81% | -94.07% | 22.81% | -15.96% | -73.82% | 23.66% | -19.48% | 18.47% | -665.81% | |
| Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) | 25.93% | -13.26% | 13.84% | 34.77% | -41.28% | 30.38% | -61.28% | -49.50% | -13.97% | -83.86% | -29.27% | -22.42% | ||||
| Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y) | -6.05% | -13.18% | -21.56% | -6.08% | ||||||||||||
| Net Income towards Common Stockholders (QoQ)Net Income (QoQ) | -2.45% | 34.20% | -662,557,278.49% | 100.00% | -56.65% | 49.94% | -501,604,112.76% | 100.00% | 22.81% | -15.96% | -464,976,509.17% | 100.00% | -24.53% | 18.47% | -440,333,737.41% | |
| Net Margin Growth (1y) | 0.00B | 121.00 | 26.00 | -11.82B | -0.00B | -0.00B | -0.00B | 8.81B | 0.00B | -0.00B | -0.00B | -37.15B | ||||
| Net Margin Growth (3y) | -0.00B | -0.00B | -0.00B | -40.16B | ||||||||||||
| Net Margin (QoQ) | -825.00 | 0.00B | -26.38B | 26.38B | -0.00B | 0.00B | -38.20B | 38.20B | 0.00B | 0.00B | -29.39B | 29.39B | -0.00B | -0.00B | -66.54B | |
| Operating Income Growth (1y)Op. Inc Growth (1y) | -3.68% | -46.22% | 10.88% | 77.10% | -31.07% | 5.95% | -66.12% | -276.83% | -9.78% | -26.58% | -26.15% | -497.75% | ||||
| Operating Income Growth (3y)Op. Inc Growth (3y) | -14.26% | -20.29% | -23.15% | -72.78% | ||||||||||||
| Operating Income (QoQ)Op. Inc (QoQ) | 8.14% | 10.55% | -161.80% | 51.81% | -29.56% | 45.48% | 32.74% | -175.87% | 7.03% | 3.70% | -52.58% | 19.63% | -7.19% | 4.03% | -622.98% | |
| Operating Margin Growth (1y) | -964.00 | -0.00B | -167.00 | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | ||||
| Operating Margin Growth (3y) | -0.00B | -0.00B | -0.00B | -0.00B | ||||||||||||
| Operating Margin (QoQ) | 222.00 | 0.00B | -0.00B | 0.00B | -875.00 | 0.00B | 779.00 | -0.00B | 0.00B | 0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |
| Profit After Tax Growth (1y)PAT Growth (1y) | 30.79% | -58.58% | 11.39% | 63.84% | -63.88% | 31.28% | -63.54% | -139.40% | -12.83% | -60.82% | -49.51% | -450.50% | ||||
| Profit After Tax Growth (3y)PAT Growth (3y) | -8.57% | -20.57% | -29.40% | -68.28% | ||||||||||||
| Profit After Tax (QoQ)PAT (QoQ) | 23.92% | 21.41% | -228.79% | 64.80% | -74.32% | 56.08% | -34.17% | -59.54% | 26.90% | -4.51% | -96.41% | 24.81% | -4.20% | 2.84% | -623.19% | |
| Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) | -6.93% | -21.90% | -16.06% | -12.83% | -12.88% | -11.44% | -11.24% | |||||||||
| Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y) | -14.78% | -16.18% | -13.42% | |||||||||||||
| Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) | -4.92% | -10.02% | -6.17% | -3.29% | -2.67% | -3.34% | -3.51% | -2.44% | ||||||||
| Return on Assets [ROA] Growth (1y)ROA Growth (1y) | 431.00 | -0.00B | ||||||||||||||
| Return on Assets [ROA] (QoQ)ROA (QoQ) | -651.00 | -25.00 | -0.00B | -0.00B | -0.00B | |||||||||||
| Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) | -712.00 | |||||||||||||||
| Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) | -848.00 | -473.00 | ||||||||||||||
| Return on Equity [ROE] Growth (1y)ROE Growth (1y) | -0.00B | |||||||||||||||
| Return on Equity [ROE] (QoQ)ROE (QoQ) | -0.00B | -988.00 | ||||||||||||||
| Return on Sales [ROS] Growth (1y)ROS Growth (1y) | -964.00 | -0.00B | -167.00 | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | ||||
| Return on Sales [ROS] Growth (3y)ROS Growth (3y) | -0.00B | -0.00B | -0.00B | -0.00B | ||||||||||||
| Return on Sales [ROS] (QoQ)ROS (QoQ) | 222.00 | 0.00B | -0.00B | 0.00B | -875.00 | 0.00B | 779.00 | -0.00B | 0.00B | 0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |
| Revenue Growth (1y) | -7.89% | 14.55% | -13.46% | -54.95% | -59.16% | -59.48% | -11.82% | 94.30% | 83.04% | 4.93% | -60.54% | -45.93% | ||||
| Revenue Growth (3y) | -11.69% | -21.32% | -32.98% | -22.07% | ||||||||||||
| Revenue (QoQ) | -5.40% | 19.13% | 49.41% | -45.30% | 17.65% | -10.00% | -22.22% | -50.41% | 16.72% | 95.85% | 71.38% | -53.28% | -33.09% | -26.35% | 134.86% | |
| Total Debt Growth (1y) | -0.51% | 1.46% | 9.82% | 13.45% | ||||||||||||
| Total Debt (QoQ) | -0.65% | 0.58% | 1.31% | 0.65% | 7.09% |
Pull CASI Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=CASIF&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "CASIF", "statement": "Growth", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=CASIF&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();